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THE ROLE OF ALLERGY IN THE AETIOLOGY OF UVEITIS
PROF. M. H. LUNTZ, Department of Ophthalmology, University of the Witwatersrand, Johannesburg
The purpose of this communication is to examine and
analyse the role played by allergy in the aetiology of
uveitis, with particular reference to endogenous anterior
uveitis.
One defines allergy as 'the changed capacity of an indi-
vidual to react to a foreign substance', and the disease is
based on an antigen-antibody reaction causing hypersensi-
tivity, usually to a bacteria or its soluble products or a
foreign protein; moreover, the protein need not be foreign
for an individual may react to one of his own proteins and
this is called 'auto-immune disease'. Immediate and delayed
reactions are recognized and both types can be demon-
strated in uveitis.
The postulate that anterior uveitis is due to an immuno-
pathological disease is based on at least 5 major premises:
(i) Indirect evidence. The presence of bacteria, viruses,
parasites, fungi, nematodes or other organisms has never
been proved in anterior uveitis except in rare cases. How-
ever, this negative evidence still- awaits examination by
electron-microscopic studies.
(ii) Direct evidence. Implicating immunological and
allergic reactions in patients with uveitis, e.g. Hallett et aI.'
have shown that patients with uveitis have a high incidence
of complement to uvea, compared with patients with other
ocular disease and persons with normal eyes.
- (iii) The close association of uveitis with diseases thought
to be due to immunopathology, e.g. rheumatoid arthritis,
ankylosing spondylitis and various collagen diseases.
(iv) Atopic uveitis, e.g. after ingestion of beef protein
and in patients hypersensitive to animal dander, house dust
and pollen. These are rare instances.
(v) Experimental evidence that ocular tissues, and in par-
ticular the uvea, are able to support the typical Arthus
phenomenon, delayed hypersensitivity, transplantation-
immunity (with corneal grafting) and auto-allergic mecha-
nisms, e.g. to lens and uveal proteins. Uveitis can be pro-
duced experimentally by immunological techniques.
Before proceeding further it is necessary to state certain
general considerations concerning allergy as it affects the
eye. For an organ to react immunologically it is necessary
for it to be exposed to an antigenic substance, to develop
a hypersensitivity state to that substance and then, at a
subsequent exposure to the same antigen, an immunological
reaction occurs. The hypersensitive state may be mediated
by antibodies present in the circulation (humoral anti-
bodies) or by sensitized cells that are present locally in the
organ (delayed hypersensitivity).
The eye is unique in being precluded from immunolo-
gical injury by humoral antibodies because of the so-called
blood-aqueous and blood-vitreous barriers, which insulate
the anterior humours from the immunological activity of
the body as a whole. Therefore, immunopathological reac-
tions in the eye must depend on the ability of the organ to
produce immunologically competent cells and local anti-
body. Witmer,18 using fluorescein-labelled antibody, has
demonstrated experimentally the ability of the eye to react
in this way and Wolcowicz et al.' were able to show that
continuous production of antibody by ocular tissues after
antigenic stimulation will occur in tissue culture of these
ocular tissues. Also of interest is the well-known observa-
tion that the typical histological picture of a subsiding non-
granulomatous uveitis is often dominated by a plasmacy-
tosis, which suggests that local antibody formation is in
progress.
After exposure of the eye to an antigen, for example
by intra-vitreous injection of the antigen, the eye becomes
red and congested and uveitis develops, presumably owing
to a state of local hypersensitivity in which immunologic-
ally competent cells are produced and proliferate in the
eye, especially the uvea, producing antibody. The eye then
settles down, returning to a normal appearance, but the
ability to react to the specific antigen by producing im-
munologically competent cells remains. If that eye is sub-
sequently exposed to the same antigen, it will react by
producing local antibody; this production of local anti-
body which remains 'fixed' in the eye and is thought to be
an important factor in 'local ocular hypersensitivity' sensi-
tized the eye to the systemically introduced antigen. One
should point out that this same sequence of events, should
it occur in a lymph node, would probably pass unnoticed
and be regarded as subclinical, but because of the exqui-
site sensitivity of the visual function of the eye this degree
of reaction will produce a recognizable clinical disease,
manifesting very often as uveitis. It is by no means clear
why the uvea is so often the shock organ in the eye.
Silverstein' puts it as follows: 'Hence the act of antibody
production in the eye may represent a contributing factor
in the pathogenesis of uveitis'.
It is postulated that repeated exposure of an eye already
sensitized to a specific antigen will produce repeated epi-
sodes of local immunological reactions affecting predomi-
nantly the uvea and these will be interpreted clinically
as repeated attacks of non-granulomatous uveitis. It is pos-
sible that a similar mechanism may be implicated in re-
peated attacks of granulomatous uveitis.
EXPERIMENTAL EVIDENCE FOR UVEITIS OWING TO LOCAL
ORGAN HYPERSENSITIVITY
Parenteral administration of an antigen does not in general
result in a lesion from this first exposure. The antigen is
fairly rapidly removed from the site of the injection and
disseminated throughout the body so that by the time the
immunological response has developed there will be no
antigen remaining at the original site, but this is not so in
the eye.
A week or 10 days following the injection of a suluble
protein antigen into the vitreous body, a spontaneous
uveitis develops in the injected eye which is characterized
by lymphocytes and monocytes in the early stages and
plasma cells later.' The vitreous body forms a natural
depot for antigenic products," and their slow escape
(through the injection site) allows hypersensitivity to deve-
lop while the antigen is still present in the eye.
Following an attack of uveitis the eye returns to normal,
but recurrent attacks can be produced for many months
afterwards by injecting either intravenously or intracuta-
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neously or ingesting the specific antigen, as the response
is highly specific for the antigen.
The eye is normally insulated from circulating proteins.
One may, therefore, ask how an antigen may enter the eye
and sensitize ocular tissue, which constitutes the first stage
of local ocular hypersensitivity. According to Silverstein'
there are 2 possibilities:
(i) The most obvious is that the antigens involved in the
pathogenesis of uveitis are proteins within the eye, e.g.
lens and uvea, and that uveitis is an auto-allergic disease.
(ii) During the course of a mild bacteraemia accompany-
ing an infection elsewhere, a few organisms may lodge in the
uvea and reside there for a time, resulting in local sensi-
tization. Penetration of organisms or protein into the eye
would be facilitated by trauma or during ocular inflamma-
tion.' Woods" believes that most cases of non-granuloma-
tous uveitis are due to local hypersensitivity to streptococ-
cal protein.
To these 2 possibilities I shall add a third and fourth:
(iii) That the blood-aqueous and blood-vitreous barrier
can be breached by a high concentration of circulating
antigen so that antigen or a non-protein substance (hapten)
may gain access to the ocular humours and, if a hapten,
combine with a protein, e.g. lens or uvea, to form an
antigen.
(iv) The antigenic potential of even minute quantities of
antigen that gains access to the eye may be enhanced con-
siderably by an immunological adjuvant such as bacterial
protein, which may be present during a bacteraemia from
an area of infection outside the eye.
These 2 postulates are strongly supported by experi-
mental work.
Uveitis can be produced in guinea-pigs following paren-
teral sensitization and challenge of the animals with hetero-
logous uveal protein injection into multiple sites. The
uveitis occurs more frequently and the reaction is enhanced
if complete Freund's adjuvant is mixed with the antigen.
In this experiment uveal protein is delivered in high con-
centration so that it can gain access to the eye through the
blood-aqueous and blood-vitreous barriers while its anti-
genic potential is enhanced by the use of complete Freund's
adjuvant.8
A similar but more intense reaction is obtained when
the challenging dose of uveal protein is delivered subcon-
junctivally to a previously sensitized animal; the reaction
is considerably greater when Freund's adjuvant is given at
the same time but at a different site (thigh). Ocular trauma
alone, i.e., without delivering uveal protein, produces no
reaction in the eye.' Of great interest is the fact that under
these experimental conditions the degree of uveitis bears
no relationship to the presence of circulating antibody and
if this is present, to its concentration.' It seems, therefore,
that under the conditions of this experiment the presence
of circulating antibody constitutes no protection against
local ocular hypersensitivity.
The application of this experimental fact to uveitis in
man is important. One would like to know whether the
degree of uveitis in man bears any relationship to the pre-
sence (and, if present, the concentration) of circulating anti-
body. If the postulate of local ocular hypersensitivity is
correct, then circulating antibody should protect the eye
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from an attack of uveitis by removing systemic antigen.
Hence severe uveitis should be associated with a Iow or
absent serum antibody titre.
We are indebted to Woods" for the suggestion that non-
granulomatous anterior uveitis is an allergic disease. He
postulated that in most cases it is a reaction to strepto-
coccal protein of the delayed bacterial type, based on his
observation that in patients with non-granulomatous
uveitis, 89% had positive skin tests to various strains of
streptococcus, while in a control group with granulomatous
uveitis only 20% were hypersensitive. The iritis improved
when desensitization was attempted. Woods" believed the
l1vea became sensitized by streptococcal protein in the
blood derived from an area of focal sepsis and when re-
exposed to the antigen during a subsequent bacteraemia.
acute uveitis developed. This postulate is not generally ac-
cepted because:
(i) Results of skin tests must be viewed with caution.
A positive result does not necessarily indicate specific hy-
persensitivity of a particular tissue because non-specific
skin reactions, owing to impurities in the preparation of
the antigen, are not uncommon. Fair skins react more in-
tensely than dark skins, and the reaction depends also on
the amount of local histamine in the skin or circulating
inhibiting drugs, e.g. corticosteroids: Finally Lawrence'·
showed that positive skin reactions to streptococcal pro-
teins occur in a relatively large segment of a random hos-
pital population.
(ii) Studies on antistreptolysin titres on serum and
aqueous humour of patients with uveitis have been incon-
clusive.
(iii) Attempts to produce microbial ocular allergy in ani-
mals have been unsuccessful. -
If one accepts that uveitis is not due to microbial allergy,
what allergens apart from endogenous ocular proteins
might be responsible?
Uveitis is closely associated with certain generalized
diseases such as ankylosing spondylitis, rheumatoid arth-
ritis, Reiter's syndrome. A protein antigen, as yet undis-
covered, may be the common aetiological factor. In this
context the discovery of high titres of antibody to protein
constituents of cow's milk in cases of ulcerative colitis with
ankylosing spondylitis is of great interest."
Finally there is the suggestion that the antigen respons-
ible for uveitis is an endogenous ocular protein, e.g. lens
protein, uveal or perhaps retinal, and that uveitis is there-
fore an auto-allergic disease. Two possible types of auto-
antigen must be considered.
(i) Autologous proteins truly antigenic to the host.
(ii) Altered autologous proteins, which in their own
natural state are non-antigenic.
Silverstein' suggested that lens protein is truly antigenic
to the host and that exposure of the host to his own un-
altered lens protein will cause a local phaco-anaphylactic
reaction, as described by Verhoeff and Lemoine."
Sympathetic ophthalmia on the other hand is due to
sensitization of the individual to altered autologous uveal
protein:
The assumption that autologous lens protein is antigenic
to the host whereas uveal protein in unaltered form is not,
is based on the belief that lens protein is isolated from the
792 S.A. MEDICAL JOURNAL 10 September 1966
rest of the eye and the body early in development, so that
it behaves as a 'foreign' protein, whereas normal uveal
protein is not so insulated and therefore not 'foreign'. It
has been shown, however, that lens protein is not confined
to the lens, but is more widely distributed in the eye" and
that antibodies to lens can be demonstrated in the serum
of normal persons."
My own experiments suggest that lens protein, at any
rate in the guinea-pig, is a very weak antigen and to pro-
duce phaco-anaphylaxis it has to be boosted with adjuvant.
BurkylS came to the same conclusion in 1934. This can be
demonstrated experimentally as follows:
The lens in one eye of a guinea-pig is needled, thus expos-
ing the eye to autologous lens protein. Ten days later the
second eye is needled and both eyes are examined histolo-
gically a week later. If Freund's adjuvant is not used, a
mononuclear reaction develops in the second eye; how-
ever, if complete Freund's adjuvant is injected into the
thigh at the same time the second eye is needled, the histo-
logical picture is characterized by a polymorphonuclear
reaction as in the human disease.
Sympathetic ophthalmia can be produced experimentally
by injecting heterologous uveal protein into the vitreous
or subconjunctivally into previously sensitized guinea-pigs.
Where lens protein is used instead of uveal protein, experi-
mental sympathetic ophthalmia does not develop.
Apart from this experimental evidence that phaco-
anaphylaxis and sympathetic ophthalmia may have an
auto-allergic aetiology there is also clinical evidence:
(i) Temporal aspects, for example an initial exposure of
the eye to lens protein may be followed after a latent
period by phaco-anaphylaxis if the eye is re-exposed to
lens.
(ii) Patients with phaco-anaphylaxis exhibit antibodies
to lens protein in their serum.'-
(iiz) Woods" demonstrated anti-uveal antibodies in
patients with perforating injuries of the globe.
(iv) Extracts of uveal tissue elicited a positive intra-
dermal hypersensitivity test in patients with sympathetic
ophthalmia. Woods" and Friedenwald" showed that the
histology of the intradermal test was similar to that of the
choroidal lesions. Witmer" demonstrated local antibody to
uvea in a case of sympathetic ophthalmia.
(v) Hypersensitivity to lens protein antigen has been
transferred from a patient with phaco-anaphylaxis to
guinea-pigs,'-
SUMMARY
Hypersensitivity to protein and in particular uveal and
lens protein can fairly be stated to play a major role in the
aetiology of uveitis. The evidence for this is :
(i) Direct: in the form of clinical characteristics of the
disease, especially phaco-anaphylaxis and sympathetic
ophthalmia and the evidence for an immunopathological
reaction.
(iz) Experimental: of which there is a substantial and
impressive body of evidence and
(iiz) Indirect: as no other aetiological agent has been dis-
covered in spite of intensive investigations.
The offending antigen or antigens may be a bacterial
protein producing a delayed hypersensitivity reaction in
the eye, although this is unlikely for reasons presented in
this paper or the more likely possibility of an endogenous
ocular protein, either boosted by an adjuvant or modified.
This type of auto-allergic disease is manifested most
strikingly in phaco-anaphylaxis and sympathetic ophthal-
mia, but may be responsible for other types of uveitis as
well. Finally an exogenous protein may be responsible that
is able to produce multiple organ immunopathology as for
example, in rheumatoid arthritis, ankylosing spondylitis or
Reiter's syndrome, the ocular lesion being part of a
generalized disease process. It is possible that one or more,
or all of these antigens, are responsible for the disease, but
in the present state of our knowledge one can say no more
than this.
Whatever the antigen responsible, local ocular hyper-
sensitivity probably plays the major role in the patho-
genesis of the disease and explains the recurrences alternat-
ing with complete remissions so characteristic of the
disease. This type of immunological response, almost
unique to the eye, is the result of certain anatomical and
physiological factors which are peculiar to the eye. How-
ever, one must bear in mind that in experimental uveitis in
guinea-pigs, the degree of uveitis bears no relationship to
the level of circulating precipitins.
No doubt, as research into uveitis continues, the import-
ance of these unique anatomical and physiological proper-
ties and the unusual immunological characteristics of the
eye will emerge as important aetiological factors in non-
granulomatous uveitis, although they do not explain why
the uvea is so often the shock organ. In the granulomatous
form of uveitis, in which active infection with an organism
occurs, hypersensitivity probably plays an important acces-
sory role in the formation of the granulomatous lesion
although the evidence here is not as convincing as that
which exists for non-granulomatous uveitis.
This work was supported by a grant from the CSIR and
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